Allarity Therapeutics Inc (ALLR)

May 02, 2025

ALLR ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Allarity Therapeutics, Inc. - ACCESS Newswire

May 02, 2025

May 02, 2025

You might want to take a look at Allarity Therapeutics Inc (ALLR) now - Sete News

May 02, 2025

Apr 30, 2025

Was anything positive for Allarity Therapeutics Inc (ALLR) stock last session? - uspostnews.com

Apr 30, 2025

Apr 29, 2025

The Psychology of Allarity Therapeutics Inc Inc. (ALLR) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 29, 2025

Apr 29, 2025

Upward Trajectory: Allarity Therapeutics Inc (ALLR) Posts a Slidee, Closing at 1.07 - DWinneX

Apr 29, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 25, 2025

Allarity unveils new multiple myeloma treatment predictor - Investing.com

Apr 25, 2025

Apr 25, 2025

Allarity unveils new multiple myeloma treatment predictor By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 25, 2025

Healthy Upside Potential: Allarity Therapeutics Inc (ALLR) - Sete News

Apr 25, 2025

Apr 25, 2025

Allarity Therapeutics Presents Novel Drug Response - GlobeNewswire

Apr 25, 2025

Apr 25, 2025

Novel AI Predictor Identifies Multiple Myeloma Patients for Targeted Treatment | ALLR Stock News - Stock Titan

Apr 25, 2025

Apr 25, 2025

Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025 - Yahoo

Apr 25, 2025

Apr 23, 2025

Ratios Revealed: Decoding Allarity Therapeutics Inc (ALLR)’s Financial Health - DWinneX

Apr 23, 2025

Apr 22, 2025

How to interpret Allarity Therapeutics Inc (ALLR)’s stock chart patterns - uspostnews.com

Apr 22, 2025

Apr 21, 2025

Allarity Therapeutics Inc (ALLR) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Apr 21, 2025

Apr 16, 2025

Allarity Therapeutics Restructures Board of Directors - TipRanks

Apr 16, 2025

Apr 14, 2025

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - PR Newswire

Apr 14, 2025

Apr 10, 2025

Allarity Therapeutics stock hits 52-week low at $0.67 - Investing.com

Apr 10, 2025

Apr 09, 2025

Allarity Therapeutics stock hits 52-week low at $0.67 By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 08, 2025

There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News

Apr 08, 2025

Apr 08, 2025

ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 08, 2025

Apr 08, 2025

ALLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire

Apr 08, 2025

Apr 04, 2025

Allarity Therapeutics Inc (ALLR) Is A Good Stock To Invest In - Stocksregister

Apr 04, 2025

Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025

Apr 02, 2025

ALLR Stockholders Have Opportunity to Lead Allarity Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Apr 02, 2025

Apr 01, 2025

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert - Benzinga

Apr 01, 2025

Apr 01, 2025

XPeng, Ultralife And 3 Stocks To Watch Heading Into Tuesday - Benzinga

Apr 01, 2025

Mar 31, 2025

Allarity Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Allarity's Cancer Drug Shows 17-Month Benefit as Cash Runway Extends to 2027 - Stock Titan

Mar 31, 2025

Mar 31, 2025

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Update - The AM Reporter

Mar 31, 2025

Mar 26, 2025

Allarity Therapeutics (NASDAQ:ALLR) Trading 11% Higher – Still a Buy? - Defense World

Mar 26, 2025

Mar 25, 2025

Allarity Therapeutics probes potential stock manipulation By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 24, 2025

Allarity Therapeutics probes potential stock manipulation - Investing.com

Mar 24, 2025

Mar 24, 2025

Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares - GlobeNewswire

Mar 24, 2025

Mar 24, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 24, 2025

Mar 24, 2025

Allarity Takes Bold Action Against Market Manipulation: Launches High-Tech Trading Investigation - Stock Titan

Mar 24, 2025

Mar 20, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

Mar 20, 2025

Mar 19, 2025

ALLR Shareholders Are Encouraged To Join Allarity Therapeutics, Inc. Securities Fraud Investigation With The Schall Law Firm - MENAFN.COM

Mar 19, 2025

Mar 17, 2025

Allarity Therapeutics Announces Presentation of Phase 2 - GlobeNewswire

Mar 17, 2025

Mar 17, 2025

Allarity Therapeutics Presents Positive Phase 2 Data For Stenoparib In Advanced Ovarian Cancer - Nasdaq

Mar 17, 2025